These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

573 related articles for article (PubMed ID: 35899019)

  • 21. Intraoperative neurophysiological assessment of disabling symptoms in DBS surgery.
    Journee HL; Postma AA; Staal MJ
    Neurophysiol Clin; 2007 Dec; 37(6):467-75. PubMed ID: 18083503
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Cortical disinhibition in Parkinson's disease.
    Ammann C; Dileone M; Pagge C; Catanzaro V; Mata-Marín D; Hernández-Fernández F; Monje MHG; Sánchez-Ferro Á; Fernández-Rodríguez B; Gasca-Salas C; Máñez-Miró JU; Martínez-Fernández R; Vela-Desojo L; Alonso-Frech F; Oliviero A; Obeso JA; Foffani G
    Brain; 2020 Dec; 143(11):3408-3421. PubMed ID: 33141146
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Are there differences in cortical excitability between akinetic-rigid and tremor-dominant subtypes of Parkinson's disease?
    Khedr EM; Lefaucheur JP; Hasan AM; Osama K
    Neurophysiol Clin; 2021 Oct; 51(5):443-453. PubMed ID: 34588134
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Small-amplitude cortical myoclonus in Parkinson's disease: physiology and clinical observations.
    Caviness JN; Adler CH; Beach TG; Wetjen KL; Caselli RJ
    Mov Disord; 2002 Jul; 17(4):657-62. PubMed ID: 12210853
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Transcranial magnetic stimulation follow-up study in early Parkinson's disease: A decline in compensation with disease progression?
    Kojovic M; Kassavetis P; Bologna M; Pareés I; Rubio-Agusti I; Berardelli A; Edwards MJ; Rothwell JC; Bhatia KP
    Mov Disord; 2015 Jul; 30(8):1098-106. PubMed ID: 25753906
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Pallidal stimulation for Holmes tremor: clinical outcomes and single-unit recordings in 4 cases.
    Kilbane C; Ramirez-Zamora A; Ryapolova-Webb E; Qasim S; Glass GA; Starr PA; Ostrem JL
    J Neurosurg; 2015 Jun; 122(6):1306-14. PubMed ID: 25794341
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Improvement of motor performance and modulation of cortical excitability by repetitive transcranial magnetic stimulation of the motor cortex in Parkinson's disease.
    Lefaucheur JP; Drouot X; Von Raison F; Ménard-Lefaucheur I; Cesaro P; Nguyen JP
    Clin Neurophysiol; 2004 Nov; 115(11):2530-41. PubMed ID: 15465443
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Sex differences in Parkinson's disease: A transcranial magnetic stimulation study.
    Kolmancic K; Perellón-Alfonso R; Pirtosek Z; Rothwell JC; Bhatia K; Kojovic M
    Mov Disord; 2019 Dec; 34(12):1873-1881. PubMed ID: 31603570
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The interindividual variability of transcranial magnetic stimulation effects: Implications for diagnostic use in movement disorders.
    Latorre A; Rocchi L; Berardelli A; Bhatia KP; Rothwell JC
    Mov Disord; 2019 Jul; 34(7):936-949. PubMed ID: 31322773
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Neuronal inhibition and synaptic plasticity of basal ganglia neurons in Parkinson's disease.
    Milosevic L; Kalia SK; Hodaie M; Lozano AM; Fasano A; Popovic MR; Hutchison WD
    Brain; 2018 Jan; 141(1):177-190. PubMed ID: 29236966
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Examination of central gait control mechanisms in Parkinson's disease using movement-related potentials.
    Shoushtarian M; Murphy A; Iansek R
    Mov Disord; 2011 Nov; 26(13):2347-53. PubMed ID: 21739471
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Parkinsonism in essential tremor cases: A clinicopathological study.
    Rajput AH; Rajput EF; Bocking SM; Auer RN; Rajput A
    Mov Disord; 2019 Jul; 34(7):1031-1040. PubMed ID: 31180613
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Clinical neurophysiology in movement disorders.
    Apartis E
    Handb Clin Neurol; 2013; 111():87-92. PubMed ID: 23622153
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [The diagnostic and therapeutic application of transcranial magnetic stimulation].
    Derejko M; Niewiadomska M; Rakowicz M
    Neurol Neurochir Pol; 2005; 39(5):389-96. PubMed ID: 16273463
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Electrophysiological studies of myoclonus.
    Shibasaki H; Hallett M
    Muscle Nerve; 2005 Feb; 31(2):157-74. PubMed ID: 15547927
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Driving motor cortex oscillations modulates bradykinesia in Parkinson's disease.
    Guerra A; Colella D; Giangrosso M; Cannavacciuolo A; Paparella G; Fabbrini G; Suppa A; Berardelli A; Bologna M
    Brain; 2022 Mar; 145(1):224-236. PubMed ID: 34245244
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A direct relationship between oscillatory subthalamic nucleus-cortex coupling and rest tremor in Parkinson's disease.
    Hirschmann J; Hartmann CJ; Butz M; Hoogenboom N; Ozkurt TE; Elben S; Vesper J; Wojtecki L; Schnitzler A
    Brain; 2013 Dec; 136(Pt 12):3659-70. PubMed ID: 24154618
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Synchrony Drives Motor Cortex Beta Bursting, Waveform Dynamics, and Phase-Amplitude Coupling in Parkinson's Disease.
    O'Keeffe AB; Malekmohammadi M; Sparks H; Pouratian N
    J Neurosci; 2020 Jul; 40(30):5833-5846. PubMed ID: 32576623
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The diagnosis of manganese-induced parkinsonism.
    Cersosimo MG; Koller WC
    Neurotoxicology; 2006 May; 27(3):340-6. PubMed ID: 16325915
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Local field potential beta activity in the subthalamic nucleus of patients with Parkinson's disease is associated with improvements in bradykinesia after dopamine and deep brain stimulation.
    Ray NJ; Jenkinson N; Wang S; Holland P; Brittain JS; Joint C; Stein JF; Aziz T
    Exp Neurol; 2008 Sep; 213(1):108-13. PubMed ID: 18619592
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 29.